GSK 6-K: Dividend change
Filed with the SEC on · accession 0001654954-26-009585
GSK filed a 6-K (foreign company report) with the SEC on Nov 6, 2026. GSK plc published provisional dividend dates for 2027, including ex-dividend, record, DRIP election, and payment dates for its ordinary shares and American Depositary Shares. The stock moved +0.3% by the first close after the filing.
Summary of the filing
GSK plc published provisional dividend dates for 2027, including ex-dividend, record, DRIP election, and payment dates for its ordinary shares and American Depositary Shares. The dates are indicative and subject to change.
Key details
How GSK stock reacted
Close before
$50.41
Nov 5, 2026
First close after
+0.27%
$50.55
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for GSK, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for GSK?
Click hereFrequently asked questions
What did GSK file with the SEC on Nov 6, 2026?
GSK filed a 6-K (Dividend change). GSK plc published provisional dividend dates for 2027, including ex-dividend, record, DRIP election, and payment dates for its ordinary shares and American Depositary Shares. The dates are indicative and subject to change.
What does a dividend change mean for GSK stock?
Usually: fewer shares means each remaining share owns more of the company. It matters whether the company actually buys and at what price.
How do I read a 6-K?
How foreign companies listed in the US report news and events — like an 8-K for them. Look at the exhibit names: "results", "resign", "notice" tell you the topic. Many 6-Ks are routine (meeting notices); results and leadership changes matter most.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 6-K (foreign company report): How foreign companies listed in the US report news and events — like an 8-K for them.
How did GSK stock react to this filing?
GSK closed at $50.41 before the filing and $50.55 on Nov 6, 2026 (+0.27%).
Other GSK SEC filings
- 6-K · SEC filingNov 2, 2026
- 6-K · SEC filingOct 28, 2026
- 6-K · Fda approvalOct 26, 2026
- 6-K · Fda approvalOct 26, 2026
- 6-K · Fda approvalOct 26, 2026
- 6-K · Insider sale plannedOct 26, 2026
- 6-K · Fda approvalOct 21, 2026
- 6-K · Fda approvalOct 19, 2026
- 6-K · Fda approvalOct 19, 2026
- 6-K · SEC filingOct 15, 2026
Get alerts when GSK files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days